Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
A Single-Arm Phase Ib/II Study of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Clin. Cancer Res 2022 Oct 13;[EPub Ahead of Print], TW Chen, CL Hsu, RL Hong, JC Lee, K Chang, CW Yu, SC Chen, JC Guo, ML Chen, MC Hsu, TF Kung, AL Cheng, CC YenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.